Table 6.
Model Generated from All Predictors
| Effect | Estimate | Standardized Est |
|---|---|---|
| Intercept | 4.027342 | 0 |
| Baseline Visit Count | 0.002189 | 0.02615 |
| Baseline Occupational Visit Count | 0.008477 | 0.01229 |
| Bupropion Rx in Baseline (Y/N) | 0.020813 | 0.00265 |
| Non-Opioid Analgesics Rx Count (CN103) | 0.001982 | 0.005 |
| Sedative/Hypnotics, Other Rx Count (CN309) | 0.002925 | 0.00222 |
| Tricyclic Antidepressants Rx Count (CN601) | 0.001475 | 0.00207 |
| Local Anesthetics, Topical Rx Count (DE700) | 0.016648 | 0.00492 |
| Calcium Rx Count (TN402) | -0.050907 | -0.01654 |
| Decongestants, Systemic Rx Count (RE200) | 0.030669 | 0.00639 |
| Platelet Aggregation Inhibitors Rx Count (BL700) | 0.001719 | 0.00095 |
| Distinct VA Drug Class Rx | 0.017323 | 0.07921 |
| Baseline Surgery Count | -0.007242 | -0.00202 |
| Days End of Prednisone | -0.000873 | -0.09417 |
| Baseline PDC for Etanercept | -0.102578 | -0.01393 |
| Days Start of Golimumab | -0.000198 | -0.00133 |
| Baseline PDC for Non-Biologic DMARDs | -0.662683 | -0.15295 |
| Start Methotrexate in 14 Days after Index Date (Y/N) | 0.037588 | 0.00557 |
| Start in TNFi Biologic DMARDs in 14 Days after Index Date (Count of distinct Rx) | 0.446665 | 0.05081 |
| Start in Non-Biologic DMARDs in 14 Days after Index Date (Count of distinct Rx) | 0.352313 | 0.08893 |
| Start in Steroid in 14 Days after Index Date (Count of distinct Rx) | 0.173564 | 0.02505 |
| Disease of Mouth Excluding Dental Dx Count in Baseline (CCS137) | 0.03199 | 0.00289 |
| Calculus of Urinary Tract Dx Count in Baseline (CCS160) | -0.013249 | -0.00541 |
| Other Non-Traumatic Joint Disorders Dx Count in Baseline (CCS204) | 0.000382 | 0.00074 |
| Other Connective Tissue Disease Dx Count in Baseline (CCS211) | 0.00293 | 0.00464 |
| Disease of White Blood Cells Dx Count in Baseline (CCS63) | 0.044243 | 0.00827 |
| Conditions Associated With Dizziness or Vertigo Dx Count in Baseline (CCS93) | 0.005453 | 0.00187 |
| Baseline Labtest for Chem Panel (Y/N) | -0.314001 | -0.01912 |
| Baseline Foot Surgery (Y/N) | 0.006726 | 0.00206 |
| Baseline Hand Surgery (Y/N) | 0.106317 | 0.02977 |
| Opioid Analgesics Rx (CN101) (Y/N) | 0.183042 | 0.05861 |
| Non-Opioid Analgesics Rx (CN103) (Y/N) | 0.065908 | 0.02006 |
| Tricyclic Antidepressants Rx (CN601) (Y/N) | 0.080738 | 0.01271 |
| Antidepressants, Other Rx (CN609) (Y/N) | 0.059894 | 0.01824 |
| CNS Medications, Other Rx (CN900) (Y/N) | 0.047949 | 0.00365 |
| Loop Diuretics Rx (CV702) (Y/N) | 0.073401 | 0.01455 |
| Diagnostics, Other Rx (DX900) (Y/N) | 0.142061 | 0.03273 |
| Insulin Rx (HS051) (Y/N) | 0.002114 | 0.00069 |
| Thyroid Supplements Rx (HS851) (Y/N) | 0.00651 | 0.0013 |
| Immune Suppressants Rx (IM600) (Y/N) | 0.033029 | 0.0059 |
| Calcium Rx (TN420) (Y/N) | -0.080805 | -0.01165 |
| Baseline Occupational Visit (Y/N) | 0.045223 | 0.00908 |
| Start in Non-Biologic DMARDs in 14 Days after Index Date (Y/N) | 0.375004 | 0.08206 |
| Start in DMARDs in 14 Days after Index Date (Y/N) | 0.816375 | 0.11562 |
| Baseline Use of Sulfasalazine (Y/N) | 0.144504 | 0.03555 |
| Baseline Use of Rituximab (Y/N) | 0.028977 | 0.00226 |